Predicting Response to Treatment in Gastroesophageal Junction Adenocarcinomas: Combining Clinical, Imaging, and Molecular Biomarkers

gan Bain, Gillian H., Petty, Russell D.
Cyhoeddwyd 2010

Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma

gan Baxter, Mark A., Spender, Lindsay C., Petty, Russell D.
Cyhoeddwyd yn Br J Cancer (2020)

Cancer Treatment Helpline: a retrospective study of the NHS Tayside experience

gan Trip, Ilse, George, Sherie, Thomson, Micheal, Petty, Russell D, Baxter, Mark A
Cyhoeddwyd yn BMJ Open Qual (2021)

Real-world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review)

gan Baxter, Mark A., Petty, Russell D., Swinson, Daniel, Hall, Peter S., O'Hanlon, Shane
Cyhoeddwyd yn Int J Oncol (2021)

Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype

gan Porter, Ross J., Murray, Graeme I., Brice, Daniel P., Petty, Russell D., McLean, Mairi H.
Cyhoeddwyd yn Br J Cancer (2019)

Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma

gan Dahle-Smith, Åsa, Stevenson, David, Massie, Doreen, Murray, Graeme I., Dutton, Susan J., Roberts, Corran, Ferry, David, Osborne, Aileen, Clark, Caroline, Petty, Russell D., Miedzybrodzka, Zosia
Cyhoeddwyd yn Mol Cytogenet (2015)

Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed

gan Meemanage, Madusha, Spender, Lindsay C., Collinson, Diane, Iannetta, Joanna, Challapalli, Pranavi, Turbitt, Julie, Clark, Caroline, Baxter, Mark, Murray, Graeme, Walsh, Shaun, Miedzybrodzka, Zofia, Petty, Russell D.
Cyhoeddwyd yn Cancer Chemother Pharmacol (2020)

Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland

gan Baxter, Mark A., Murphy, John, Cameron, David, Jordan, Judith, Crearie, Christine, Lilley, Christina, Sadozye, Azmat, Maclean, Mary, Hall, Peter, Phillips, Angela, Greger, Alex, Madeleine, Jude, Petty, Russell D.
Cyhoeddwyd yn Br J Cancer (2021)

The impact of COVID-19 on systemic anticancer treatment delivery in Scotland

gan Baxter, Mark A., Murphy, John, Cameron, David, Jordan, Judith, Crearie, Christine, Lilley, Christina, Sadozye, Azmat, Maclean, Mary, Hall, Peter, Phillips, Angela, Greger, Alex, Madeleine, Jude, Petty, Russell D.
Cyhoeddwyd yn Br J Cancer (2021)

APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling

gan Petty, Russell D, Samuel, Leslie M, Murray, Graeme I, MacDonald, Graham, O'Kelly, Terrence, Loudon, Malcolm, Binnie, Norman, Aly, Emad, McKinlay, Aileen, Wang, Weiguang, Gilbert, Fiona, Semple, Scot, Collie-Duguid, Elaina SR
Cyhoeddwyd 2009